Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Laminin subunit alpha-4 (LAMA4) is one of the three components of laminin heterotrimers, key extracellular matrix glycoproteins that form the major noncollagenous constituent of basement membranes[1][2][3][5]. The protein supports cell adhesion, migration, differentiation, and signaling across multiple tissues and organ systems. In particular, LAMA4 interacts with integrins and integrin-linked kinase (ILK) to maintain endothelial integrity and myocardial performance. Deficiency or mutation disrupts cell-matrix interactions, resulting in loss of endothelial cells, cardiomyopathy, and abnormal angiogenesis in the retina[2]. The exact tissue-specific and isoform-specific functions of LAMA4 remain incompletely understood, but its structural and signaling roles in vessel morphogenesis and tissue homeostasis are well documented[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Laminin subunit alpha-4 (LAMA4).